Key result
Sex-specific biological differences alter antiplatelet therapy response and bleeding risk in women.
Why the study?
Women are underrepresented in cardiovascular studies, and concerns about differential benefit and increased bleeding with antiplatelet medications warrant a better understanding of the factors contributing to sex-related differences in platelet biology.
Understanding sex-related differences in platelet biology—including genetic polymorphisms, inflammatory markers, and hormonal influences—may inform the development of sex-specific antithrombotic regimens to optimize safety and efficacy in women.
Sex-specific platelet responses to antiplatelet therapy merit evaluation; leaves open whether regimens require sex-based adjustment.
Women are underrepresented in cardiovascular studies, even as their preponderance in the aging population steadily increases. Although concerns have been raised about the differential benefit of antiplatelet medications for women, the propensity for increased bleeding among women has also been recognized. A better understanding of the factors contributing to the observed sex-related differences in platelet biology is warranted. These factors include differences in the frequency and expression of genetic polymorphisms affecting platelet responsiveness to agonists (with and without antiplatelet therapies), which might be obtained through population-based studies and in large controlled clinical trials; inflammatory marker levels and their influence on atherothrombotic risk, and the role of specific hormones in mediating platelet activation and function. Knowledge gained about these mechanistic factors might inform the development of sex-specific antithrombotic treatment regimens that confer optimized safety and efficacy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2012) conducted a review in Cardiovascular disease / atherothrombotic risk in women. Antiplatelet therapy was evaluated. Antiplatelet therapy response and bleeding risk in women are influenced by sex-related differences in platelet biology, genetics, inflammation, and hormones.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: